Herpes Simplex Encephalitis Cerebral Organoids
Source Rybak-Wolf et al., 2023 · Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association · 10.1038/s41564-023-01405-y
Abstract
This protocol describes the generation of human cerebral organoids from induced pluripotent stem cells and their infection with HSV-1 to model herpes simplex encephalitis. The protocol enables investigation of viral pathogenesis, neuronal dysfunction, and evaluation of therapeutic interventions including antiviral and anti-inflammatory agents.
Protocol overview
18 steps across 5 phases
- a Prepare iPS cell suspension and seed into embryoid body medium
- b Replace medium (day 4)
- c Transition to neural induction medium (day 5)
- d Embed organoids in Matrigel (days 7-9)
- a Transfer organoids to ultralow-attachment plates and culture on shaker
- b Culture organoids until day 60
- a Prepare HSV-1 inoculum
- b Infect organoids with HSV-1
- c Replace medium 24 hours post-infection
- d Culture infected organoids to 1 or 3 days post-infection (dpi)
- a Prepare treatment reagents
- b Initiate treatment 8-12 hours post-infection
- c Continue culture with treatment for 1 or 3 days
- a Harvest organoids for molecular analysis
- b Perform immunostaining on cryosections
- c Perform western blot analysis
- d Perform calcium imaging of neuronal activity
- e Perform single-cell RNA sequencing (scRNA-seq)
Full SOP
Full SOPs need an account and a plan
Create an account, then get free Academic access (for verified academics) or choose a plan. Plans include step-by-step procedures, reagent concentrations, QC checklists and batch record templates.
Create an accountAlready registered? Log in
Attribution
This SOP was written by Organthis based on the published method in Rybak-Wolf et al., 2023. Once the originating laboratory has confirmed it, the SOP is marked Verified.
Something wrong with this entry? Report an issue with this protocol